PGIM
Cross-asset and fixed income research from PGIM (Prudential).
United States4 articles
Multi-AssetFixed IncomeAlternatives
Research
PGIMPrivate Markets
What's Your Alternative?
PGIM and Institutional Investor's Custom Research Lab surveyed over 250 investment decision-makers at EMEA institutions representing approximately $10 trillion in AUM to examine how allocators are deploying capital across private alternatives categories including private equity secondaries, private credit, real estate, and infrastructure. The research reveals regional differences in allocation rationale and highlights private credit as the fastest-growing sub-asset class, alongside growing interest in Article 9-compliant private alternatives funds.
PGIMMulti-Asset
Asset Allocation with Public & Private Assets
This PGIM multi-asset hub aggregates 10 research pieces covering strategic asset allocation across public and private markets, including real estate credit, private vs. public performance comparison, LP NAV estimation, reinsurance, and inflation. Topics span portfolio construction, liquidity risk, capital market assumptions, and insurance-specific strategies for institutional allocators.
PGIMPrivate Markets
mcp Annual Investor Survey 2025
Montana Capital Partners (MCP), a PGIM affiliate, surveyed investors across the Americas, Europe, the Middle East, and Asia managing ~$300 billion in private alternatives allocations, finding that PE secondaries have shifted from opportunistic liquidity tools to structural portfolio components. Key findings include 86% of respondents planning to maintain or increase PE secondaries allocations, with strongest confidence in lower mid-market secondaries and growing interest in credit secondaries and evergreen structures.
PGIMMulti-Asset
Insights from PGIM Multi-Asset Solutions Experts
PGIM's Multi-Asset Solutions and Strategic Capital Group publishes a range of thought leadership covering topics including multi-asset outlooks, insurance portfolio optimization, private credit, infrastructure, and alternatives. Featured pieces include a Q4 2025 macro outlook, yield enhancement strategies for insurance investors, and research on private equity cash flows and diversification frameworks.